Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1140558

registered interest
date	19/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Kawasaki Disease: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what support his Department is providing to (a) enable early treatment and (b) increase awareness amongst healthcare providers of Kawasaki disease .
tabling member constituency	Cardiff West
tabling member printed	Kevin Brennan
uin	279382
answer	answer is ministerial correction date of answer 26/07/2019 answer text <p>NHS Improvement has previously published a Patient Safety Alert for the attention of providers of National Health Service-funded care to emphasise the high risk and atypical presentation of coronary artery aneurysms, coronary thrombosis and myocardial ischaemia or infarction in patients with Kawasaki disease, and to highlight the importance of specialist advice.</p><p>Guidance is also available from the National Institute for Health and Care Excellence (NICE) on the assessment and initial management of fever in children under five, and this guidance includes recommendations on recognising the symptoms of Kawasaki disease.</p><p>NICE’s clinical guidelines help healthcare professionals deliver the best possible care based on the best available evidence; the guidelines are not mandatory, although health and care commissioners are expected to take them fully into account.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 26/07/2019 11:37:42 answering member 4455 label Biography information for Seema Kennedy previous answer version 131090 answering member constituency South Ribble answering member printed Seema Kennedy answering member 4455 label Biography information for Seema Kennedy
tabling member	1400 label Biography information for Kevin Brennan

1140560

registered interest
date	19/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Kawasaki Disease: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent comparative assessment he has made of the UK level of research funding into Kawasaki disease with that of other EU member states.
tabling member constituency	Cardiff West
tabling member printed	Kevin Brennan
uin	279384
answer	answer is ministerial correction date of answer 25/07/2019 answer text <p>The Department has not made a recent comparative assessment of the United Kingdom level of research funding into Kawasaki disease with that of other European Union member states.</p><p> </p><p>The EU has recently agreed to fund a Kawasaki disease study led from Great Ormond Street Hospital/University College London. The trial, which aims to recruit 262 children from 40 centres across Europe, will look at the effectiveness of using of steroids in addition to the standard treatment for Kawasaki syndrome, intravenous immunoglobulins. The award is for over €5 million in funding for the trial to be run through a new European consortium, connect4children.</p><p> </p><p>The National Institute for Health Research (NIHR) Imperial Biomedical Research Centre was funded between 2013-18 to carry out a project on the ‘Genetic determinants of Kawasaki disease for susceptibility and outcome’ with NIHR funding of £77,000.</p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 25/07/2019 14:19:10 answering member 4008 label Biography information for Dame Caroline Dinenage previous answer version 131092 answering member constituency Gosport answering member printed Caroline Dinenage answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	1400 label Biography information for Kevin Brennan

1064722

registered interest
date	21/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Services: Reciprocal Arrangements
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many times European Health Insurance Cards were used by UK citizens abroad in the past year.
tabling member constituency	Cardiff West
tabling member printed	Kevin Brennan
uin	224302
answer	answer is ministerial correction date of answer 26/02/2019 answer text <p>There were 118,684 accepted claims when a European Health Insurance Card (EHIC) was used, in the last 12 months.</p><p> </p><p>There are 3,108,739 United Kingdom-issued EHICs in circulation for people aged over 70. This is based on cards which have not expired and the applicant’s age on the date the card was issued, and not their current age. EHICs are valid for five years after their issue date.</p><p> </p><p>Information is not available on the number of times EHICs were used by UK citizens abroad to support the treatment of pre-existing conditions in the last year.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 224304 224305 question first answered 26/02/2019 16:23:35 answering member 1585 label Biography information for Stephen Hammond
tabling member	1400 label Biography information for Kevin Brennan

1064723

registered interest
date	21/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Services: Reciprocal Arrangements
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many times European Health Insurance Cards were used by people over the age of 70 in each of the last five years.
tabling member constituency	Cardiff West
tabling member printed	Kevin Brennan
uin	224303
answer	answer is ministerial correction date of answer 26/02/2019 answer text <p>The following table shows the number of European Health Insurance Card claims from people aged over 70 by year for the last five years:</p><table><tbody><tr><td><p>2014</p></td><td><p>29,632</p></td></tr><tr><td><p>2015</p></td><td><p>35,518</p></td></tr><tr><td><p>2016</p></td><td><p>43,121</p></td></tr><tr><td><p>2017</p></td><td><p>38,271</p></td></tr><tr><td><p>2018</p></td><td><p>23,172</p></td></tr></tbody></table><p><strong> </strong></p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 26/02/2019 16:22:32 answering member 1585 label Biography information for Stephen Hammond
tabling member	1400 label Biography information for Kevin Brennan

1064724

registered interest
date	21/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Services: Reciprocal Arrangements
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many European Health Insurance Cards have been issued to people over the age of 70.
tabling member constituency	Cardiff West
tabling member printed	Kevin Brennan
uin	224304
answer	answer is ministerial correction date of answer 26/02/2019 answer text <p>There were 118,684 accepted claims when a European Health Insurance Card (EHIC) was used, in the last 12 months.</p><p> </p><p>There are 3,108,739 United Kingdom-issued EHICs in circulation for people aged over 70. This is based on cards which have not expired and the applicant’s age on the date the card was issued, and not their current age. EHICs are valid for five years after their issue date.</p><p> </p><p>Information is not available on the number of times EHICs were used by UK citizens abroad to support the treatment of pre-existing conditions in the last year.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 224302 224305 question first answered 26/02/2019 16:23:35 answering member 1585 label Biography information for Stephen Hammond
tabling member	1400 label Biography information for Kevin Brennan

1064725

registered interest
date	21/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Services: Reciprocal Arrangements
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many times European Health Insurance Cards were used by UK citizens abroad to support the treatment of pre-existing conditions in the last year.
tabling member constituency	Cardiff West
tabling member printed	Kevin Brennan
uin	224305
answer	answer is ministerial correction date of answer 26/02/2019 answer text <p>There were 118,684 accepted claims when a European Health Insurance Card (EHIC) was used, in the last 12 months.</p><p> </p><p>There are 3,108,739 United Kingdom-issued EHICs in circulation for people aged over 70. This is based on cards which have not expired and the applicant’s age on the date the card was issued, and not their current age. EHICs are valid for five years after their issue date.</p><p> </p><p>Information is not available on the number of times EHICs were used by UK citizens abroad to support the treatment of pre-existing conditions in the last year.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 224302 224304 question first answered 26/02/2019 16:23:35 answering member 1585 label Biography information for Stephen Hammond
tabling member	1400 label Biography information for Kevin Brennan

1060643

registered interest
date	13/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of the UK leaving the EU on 29 March 2019 on the supply of medicines to the UK for NHS use.
tabling member constituency	Cardiff West
tabling member printed	Kevin Brennan
uin	220816
answer	answer is ministerial correction date of answer 18/02/2019 answer text <p>Our number one priority is to ensure patients continue to have unhindered access to medicines as we exit the European Union and we are working with all sectors in the supply chain to ensure this happens.</p><p> </p><p>The Government remains committed to leaving the EU with a deal. Under the conditions of the Withdrawal Agreement, there will be a two-year Implementation Period within which the Government will negotiate the United Kingdom’s future relationship with the EU. During the Implementation Period, there will be no change to the current trading arrangements with the EU/European Economic Area (EEA), meaning the supply of medicines and medical products will continue unhindered.</p><p> </p><p>As a responsible Government, we are planning for all possible exit scenarios, including ‘no deal’. Our ‘no deal’ medicines supply contingency plans include sensible mitigations for medicines that come to the United Kingdom from or via the EU/ EEA to ensure that the supply of essential medicines, is not disrupted.</p><p> </p><p>In August 2018, the Department wrote to all pharmaceutical companies that supply prescription-only and pharmacy medicines to the UK that come from, or via, the EU/EEA asking them to ensure a minimum of six weeks additional supply in the UK, over and above existing business-as-usual buffer stocks, by 29 March 2019. The response from industry has been very positive. The vast majority of companies have confirmed stockpiling plans are in place.</p><p> </p><p>On 7 December, the Government published updated reasonable worst-case scenario border disruption planning assumptions in the event of a ‘no deal’ EU exit. Medicines and medical products are prioritised in cross-Government planning, and the Department is working with relevant partners across Government and industry to ensure we have sufficient roll-on, roll-off freight capacity on alternative routes to enable these vital products to continue to move freely into the UK.</p><p> </p><p>We are confident that if everyone does what they need to do, supplies will continue unhindered. The Department does not expect to see significant changes to existing medicine supply chains or capacity in the intervening period between now and 29 March 2019, although we will be monitoring this closely.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 18/02/2019 15:10:21 answering member 1585 label Biography information for Stephen Hammond
tabling member	1400 label Biography information for Kevin Brennan

1051440

registered interest
date	30/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Kawasaki Disease
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent steps he is taking to raise awareness of the signs and symptoms of Kawasaki disease among NHS health professionals.
tabling member constituency	Cardiff West
tabling member printed	Kevin Brennan
uin	214517
answer	answer is ministerial correction date of answer 07/02/2019 answer text <p>Guidance is available from the National Institute for Health and Care Excellence (NICE) on the assessment and initial management of fever in children under five, and this guidance includes recommendations on recognising the symptoms of Kawasaki disease.</p><p> </p><p>NICE’s clinical guidelines help healthcare professionals deliver the best possible care based on the best available evidence; the guidelines are not mandatory, although health and care commissioners are expected to take them fully into account.</p><p> </p><p>Information about the symptoms, causes, diagnosis, treatment and complications of Kawasaki disease is also available on the National Health Service website.</p><p> </p><p>Furthermore, learning information and resources for clinicians about Kawasaki disease is available from Societi, The UK Kawasaki Disease Foundation. Societi engages with a range of NHS stakeholders to raise awareness of Kawasaki disease, and has a number of senior clinicians on its Scientific Advisory Board who work in leading NHS institutions and who have expertise in relevant clinical areas such as vasculitis and paediatric cardiology.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/02/2019 15:22:23 answering member 4067 label Biography information for Steve Brine
tabling member	1400 label Biography information for Kevin Brennan

1029493

registered interest
date	20/12/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Infant Mortality
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans he has to increase support for families who have suffered baby loss.
tabling member constituency	Cardiff West
tabling member printed	Kevin Brennan
uin	204429
answer	answer is ministerial correction date of answer 07/01/2019 answer text <p>The Government is working to improve the care and support received by families who experience baby loss. The Department has provided funding to Sands, the stillbirth and neonatal death charity, to work with other baby loss charities and Royal Colleges to produce the National Bereavement Care Pathway (NBCP) to reduce the variation in the quality of bereavement care provided by the National Health Service.</p><p> </p><p>The NBCP helps professionals to support families in their bereavement after any pregnancy or baby loss, be that miscarriage (including ectopic and molar pregnancy), termination of pregnancy for fetal anomaly, stillbirth, neonatal death or sudden unexpected death in infancy. In October 2018, all of the NBCP guidance materials and tools were published online.</p><p> </p><p>In addition, NHS England’s Perinatal Mental Health Team has been working with Sands to ensure that the NBCP guidelines effectively signpost universal mental health screening and referral to evidence-based interventions and support.</p><p> </p><p>Furthermore, the Pregnancy Loss Review which the Department commissioned earlier this year, has been considering the question of whether legislation should provide new rights to bereaved parents to register pregnancy loss occurring before 24 weeks gestation, as well as investigating the impact of such losses on families and how care can be improved for parents who experience this. The review has been widely consulting with parents, charities and medical professionals and is currently scheduled to be completed in early 2019.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 07/01/2019 15:16:42 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	1400 label Biography information for Kevin Brennan

990352

registered interest
date	18/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will take steps to allow patients to have access to NHS doctors willing to prescribe cannabis-based medicine in cases where their NHS doctor is unwilling to do so.
tabling member constituency	Cardiff West
tabling member printed	Kevin Brennan
uin	181179
answer	answer is ministerial correction date of answer 23/10/2018 answer text <p>NHS England expects that cannabis-based products for medicinal use should only be prescribed for indications where there is clear evidence of benefit, and in patients where there is a clinical need which cannot be met by a licensed medicine and, where established treatment options have been exhausted.</p><p> </p><p>The decision to prescribe these unlicensed medicines must be made by a specialist doctor – not a general practitioner. These doctors focus on one field of medicine such as neurology or paediatrics and are listed on the General Medical Council’s specialist register. They must make decisions on prescribing cannabis-based products for medicinal use on a case by case basis, and only when the patient has an unmet special clinical need that cannot be met by licensed products. In addition, a specialist on the General Medical Council Register should only prescribe within their own area of practice, and the decision to prescribe should be agreed by the multidisciplinary team.</p><p> </p><p>NHS England, the British Paediatric Neurology Association and the Royal College of Physicians will provide clinical advice to doctors ahead of the law change. The National Institute for Health and Care Excellence has been commissioned to develop more detailed guidelines for clinicians in the longer term.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/10/2018 16:43:24 answering member 4067 label Biography information for Steve Brine
tabling member	1400 label Biography information for Kevin Brennan